Mutations in SLC12A3 and CLCNKB and Their Correlation with Clinical Phenotype in Patients with Gitelman and Gitelman-like Syndrome

Overview

Journal J Korean Med Sci

Specialty General Medicine

Date 2016 Jan 16

PMID 26770037

Citations 22

Authors

Jae Wook Lee

Jeonghwan Lee

Nam Ju Heo

Hae Il Cheong

Jin Suk Han

Affiliations

Soon will be listed here.

Abstract

Gitelman's syndrome (GS) is caused by loss-of-function mutations in SLC12A3 and characterized by hypokalemic metabolic alkalosis, hypocalciuria, and hypomagnesemia. Long-term prognosis and the role of gene diagnosis in GS are still unclear. To investigate genotype-phenotype correlation in GS and Gitelman-like syndrome, we enrolled 34 patients who showed hypokalemic metabolic alkalosis without secondary causes. Mutation analysis of SLC12A3 and CLCNKB was performed. Thirty-one patients had mutations in SLC12A3, 5 patients in CLCNKB, and 2 patients in both genes. There was no significant difference between male and female in clinical manifestations at the time of presentation, except for early onset of symptoms in males and more profound hypokalemia in females. We identified 10 novel mutations in SLC12A3 and 4 in CLCNKB. Compared with those with CLCNKB mutations, patients with SLC12A3 mutations were characterized by more consistent hypocalciuria and hypomagnesemia. Patients with 2 mutant SLC12A3 alleles, compared with those with 1 mutant allele, did not have more severe clinical and laboratory findings except for lower plasma magnesium concentrations. Male and female patients did not differ in their requirement for electrolyte replacements. Two patients with concomitant SLC12A3 and CLCNKB mutations had early-onset severe symptoms and showed different response to treatment. Hypocalciuria and hypomagnesemia are useful markers in differentiation of GS and classical Bartter's syndrome. Gender, genotypes or the number of SLC12A3 mutant alleles cannot predict the severity of disease or response to treatment.

Citing Articles

Clinical, genetic characteristics and outcome of four Chinese patients with Bartter syndrome type 3: Further insight into a genotype-phenotype correlation.

Piao Y, Chen C, Wu D, Liu M, Li W, Chen J Mol Genet Metab Rep. 2024; 40:101112.

PMID: 39071140 PMC: 11279331. DOI: 10.1016/j.ymgmr.2024.101112.

Novel compound heterozygous variants of gene in a Chinese patient with Gitelman syndrome: a case report.

Chen W, Zhou Q, Chen H, Li H, Chen J Front Genet. 2023; 14:1067242.

PMID: 37377595 PMC: 10291089. DOI: 10.3389/fgene.2023.1067242.

A mosaic mutation in the gene causing Bartter syndrome: A case report.

Zhou L, Chen X, Xiong J, Lei L Front Pediatr. 2023; 11:1034923.

PMID: 37138571 PMC: 10149701. DOI: 10.3389/fped.2023.1034923.

Bioactive Chemical Constituents and Pharmacological Activities of Ponciri Fructus.

Lamichhane G, Pandey J, Devkota H Molecules. 2023; 28(1).

PMID: 36615447 PMC: 9821892. DOI: 10.3390/molecules28010255.

A case of Gitelman syndrome with membranous nephropathy.

Guo X, Yu S, Sun J, Mou L BMC Nephrol. 2022; 23(1):267.

PMID: 35883046 PMC: 9327143. DOI: 10.1186/s12882-022-02875-8.

References

Colussi G, Bettinelli A, Tedeschi S, De Ferrari M, Syren M, Borsa N . A thiazide test for the diagnosis of renal tubular hypokalemic disorders. Clin J Am Soc Nephrol. 2007; 2(3):454-60. DOI: 10.2215/CJN.02950906. View

Nakhoul F, Nakhoul N, Dorman E, Berger L, Skorecki K, Magen D . Gitelman's syndrome: a pathophysiological and clinical update. Endocrine. 2011; 41(1):53-7. DOI: 10.1007/s12020-011-9556-0. View

Berry M, Robinson C, Karet Frankl F . Unexpected clinical sequelae of Gitelman syndrome: hypertension in adulthood is common and females have higher potassium requirements. Nephrol Dial Transplant. 2013; 28(6):1533-42. PMC: 3685308. DOI: 10.1093/ndt/gfs600. View

Yahata K, Tanaka I, Kotani M, Mukoyama M, Ogawa Y, Goto M . Identification of a novel R642C mutation in Na/Cl cotransporter with Gitelman's syndrome. Am J Kidney Dis. 1999; 34(5):845-53. DOI: 10.1016/S0272-6386(99)70041-7. View

Monkawa T, Kurihara I, Kobayashi K, Hayashi M, Saruta T . Novel mutations in thiazide-sensitive Na-Cl cotransporter gene of patients with Gitelman's syndrome. J Am Soc Nephrol. 2000; 11(1):65-70. DOI: 10.1681/ASN.V11165. View

Melander O, Orho-Melander M, Bengtsson K, Lindblad U, Rastam L, Groop L . Genetic variants of thiazide-sensitive NaCl-cotransporter in Gitelman's syndrome and primary hypertension. Hypertension. 2000; 36(3):389-94. DOI: 10.1161/01.hyp.36.3.389. View

Jeck N, Konrad M, Peters M, Weber S, Bonzel K, Seyberth H . Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. Pediatr Res. 2000; 48(6):754-8. DOI: 10.1203/00006450-200012000-00009. View

Cruz D, Shaer A, Bia M, Lifton R, Simon D . Gitelman's syndrome revisited: an evaluation of symptoms and health-related quality of life. Kidney Int. 2001; 59(2):710-7. DOI: 10.1046/j.1523-1755.2001.059002710.x. View

Zelikovic I, Szargel R, Hawash A, Labay V, Hatib I, Cohen N . A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int. 2002; 63(1):24-32. DOI: 10.1046/j.1523-1755.2003.00730.x. View

10.

Reissinger A, Ludwig M, Utsch B, Promse A, Baulmann J, Weisser B . Novel NCCT gene mutations as a cause of Gitelman's syndrome and a systematic review of mutant and polymorphic NCCT alleles. Kidney Blood Press Res. 2003; 25(6):354-62. DOI: 10.1159/000068695. View

11.

Fukuyama S, Okudaira S, Yamazato S, Yamazato M, Ohta T . Analysis of renal tubular electrolyte transporter genes in seven patients with hypokalemic metabolic alkalosis. Kidney Int. 2003; 64(3):808-16. DOI: 10.1046/j.1523-1755.2003.00163.x. View

12.

Yoo T, Lee S, Yoon K, Baek H, Chung J, Lee T . Identification of novel mutations in Na-Cl cotransporter gene in a Korean patient with atypical Gitelman's syndrome. Am J Kidney Dis. 2003; 42(6):E11-6. DOI: 10.1053/j.ajkd.2003.08.035. View

13.

Maki N, Komatsuda A, Wakui H, Ohtani H, Kigawa A, Aiba N . Four novel mutations in the thiazide-sensitive Na-Cl co-transporter gene in Japanese patients with Gitelman's syndrome. Nephrol Dial Transplant. 2004; 19(7):1761-6. DOI: 10.1093/ndt/gfh239. View

14.

Bettinelli A, Bianchetti M, Girardin E, Caringella A, Cecconi M, Appiani A . Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr. 1992; 120(1):38-43. DOI: 10.1016/s0022-3476(05)80594-3. View

15.

Simon D, Bia M, Ellison D, Karet F, Molina A, Vaara I . Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996; 12(1):24-30. DOI: 10.1038/ng0196-24. View

16.

Simon D, Karet F, Hamdan J, Dipietro A, Sanjad S, Lifton R . Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996; 13(2):183-8. DOI: 10.1038/ng0696-183. View

17.

Simon D, Karet F, Rodriguez-Soriano J, Hamdan J, Dipietro A, Trachtman H . Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. Nat Genet. 1996; 14(2):152-6. DOI: 10.1038/ng1096-152. View

18.

Simon D, Bindra R, Mansfield T, Mendonca E, Stone R, Schurman S . Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet. 1997; 17(2):171-8. DOI: 10.1038/ng1097-171. View

19.

Abuladze N, Yanagawa N, Lee I, Jo O, Newman D, Hwang J . Peripheral blood mononuclear cells express mutated NCCT mRNA in Gitelman's syndrome: evidence for abnormal thiazide-sensitive NaCl cotransport. J Am Soc Nephrol. 1998; 9(5):819-26. DOI: 10.1681/ASN.V95819. View

20.

Fukuyama S, Hiramatsu M, Akagi M, Higa M, Ohta T . Novel mutations of the chloride channel Kb gene in two Japanese patients clinically diagnosed as Bartter syndrome with hypocalciuria. J Clin Endocrinol Metab. 2004; 89(11):5847-50. DOI: 10.1210/jc.2004-0775. View